The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Highly Active Antiretroviral Therapy and the Incidence of Non–AIDS-Defining Cancers in People With HIV Infection
Abstract
Purpose: The effect of highly active antiretroviral therapy (HAART) on the incidence of non–AIDS-defining cancers (NADCs) is unclear. Methods: We have investigated the occurrence of NADCs in a prospective cohort of 11,112 HIV-positive individuals, with 71,687 patient-years of follow-up. Standardized incidence ratios (SIRs) were calculated using general population incidence data. We investigated the effect of calendar period, HIV parameters, and immunologic and treatment-related factors on the incidence of these cancers using univariate and multivariate analyses. Results: The SIR for all NADCs was 1.96 (95% CI, 1.66 to 2.29). There was no significant excess in incidence in the pre-HAART era (1983 to 1995; SIR, 0.95; 95% CI, 0.58 to 1.47). However, the incidence increased in the early HAART period (1996 to 2001) and remains elevated in the most recent established HAART period (2002 to 2007; SIR, 2.05; 95% CI, 1.51 to 2.72, and SIR 2.49; 95% CI, 2.00 to 3.07, respectively). Multivariate analysis showed that use of HAART (hazard ratio [HR] = 1.64; 95% CI, 1.13 to 2.39) and a nadir CD4 count less than 200/μL (HR = 1.67; 95% CI, 1.10 to 2.54) were associated with an increased risk. Only the non-nucleoside reverse transcriptase inhibitors (NNRTIs) were associated with a significantly increased risk of NADCs (HR = 1.45; 95% CI, 1.01 to 2.08). Much of this association was attributable to an increased risk of Hodgkin's lymphoma with NNRTIs (HR = 2.20; 95% CI, 1.03 to 4.69). Conclusion: Since the introduction of HAART, there has been a significantly increased risk of NADCs, which has now stabilized. A number of factors are associated with this increased risk, including HAART use. There may be an association between the use of NNRTIs and the development of Hodgkin's lymphoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grulich, A. E., van Leeuwen, M. T., Falster, M. O., & Vajdic, C. M. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61050-2 · Cited by 2,323
Gazzard, B., & on behalf of the BHIVA Treatment Guidelines Writing Group (2008) · HIV Medicine · doi:10.1111/j.1468-1293.2008.00636.x · Cited by 1,089
Self-citationTreatment for Adult HIV Infection: 2006 Recommendations of the International AIDS Society–USA Panel
Hammer, S. M., Saag, M. S., Schechter, M., Montaner, J. S. G., Schooley, R. T., Jacobsen, D. M., Thompson, M. A., Carpenter, C. C. J., Fischl, M. A., Gazzard, B. G., et al. (2006) · JAMA · doi:10.1001/jama.296.7.827 · Cited by 1,033
Self-citationPatel, P., Hanson, D. L., Sullivan, P. S., Novak, R. M., Moorman, A. C., Tong, T. C., Holmberg, S. D., Brooks, J. T., & for the Adult and Adolescent Spectrum of Disease Project and HIV Outpatient Study Investigators* (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-10-200805200-00005 · Cited by 942
Clifford, G. M., Polesel, J., Rickenbach, M., Study, O. B. O. T. S. H. C., Dal Maso, L., Keiser, O., Kofler, A., Rapiti, E., Levi, F., Jundt, G., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji072 · Cited by 863
Association of Cancer With AIDS-Related Immunosuppression in Adults
Frisch, M. (2001) · JAMA · doi:10.1001/jama.285.13.1736 · Cited by 821
Trends in cancer risk among people with AIDS in the United States 1980–2002
Engels, E. A., Pfeiffer, R. M., Goedert, J. J., Virgo, P., McNeel, T. S., Scoppa, S. M., & Biggar, R. J. (2006) · AIDS · doi:10.1097/01.aids.0000238411.75324.59 · Cited by 775
International Collaboration on HIV and Cancer (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.22.1823 · Cited by 647
Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS
Biggar, R. J., Jaffe, E. S., Goedert, J. J., Chaturvedi, A., Pfeiffer, R., Engels, E. A., & Study, F. T. H. C. M. (2006) · Blood · doi:10.1182/blood-2006-05-024109 · Cited by 436
HIV Infection Is Associated with an Increased Risk for Lung Cancer, Independent of Smoking
Kirk, G. D., Merlo, C., O'Driscoll, P., Mehta, S. H., Galai, N., Vlahov, D., Samet, J., & Engels, E. A. (2007) · Clinical Infectious Diseases · doi:10.1086/518606 · Cited by 387
Cited by
A Meta-Analysis of the Incidence of Non-AIDS Cancers in HIV-Infected Individuals
Shiels, M. S., Cole, S. R., Kirk, G. D., & Poole, C. (2009) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181b327ca · Cited by 516
Beyer, J., Albers, P., Altena, R., Aparicio, J., Bokemeyer, C., Busch, J., Cathomas, R., Cavallin-Stahl, E., Clarke, N. W., Claßen, J., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mds579 · Cited by 320
Self-citationCobucci, R. N. O., Lima, P. H., de Souza, P. C., Costa, V. V., Cornetta, M. D. C. D. M., Fernandes, J. V., & Gonçalves, A. K. (2015) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2014.08.003 · Cited by 175
Genome-wide siRNA screen for mediators of NF-κB activation
Gewurz, B. E., Towfic, F., Mar, J. C., Shinners, N. P., Takasaki, K., Zhao, B., Cahir-McFarland, E. D., Quackenbush, J., Xavier, R. J., & Kieff, E. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120542109 · Cited by 108
Iribarren Díaz, M., Ocampo Hermida, A., González-Carreró Fojón, J., Longueira Suárez, R., Rivera Gallego, A., Casal Núñez, E., Ocampo Álvarez, A., & Cachay, E. (2017) · Revista Española de Enfermedades Digestivas · doi:10.17235/reed.2017.4274/2016 · Cited by 17
Metadata
- Authors
- Powles, T., Robinson, D., Stebbing, J., Shamash, J., Nelson, M., Gazzard, B., Mandelia, S., Møller, H., & Bower, M.
- Venue
- Journal of Clinical Oncology
- Published
- 2009-02-20
- Volume
- 27
- Issue
- 6
- Pages
- 884-890
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2006152917
- Cited by
- 360
- References
- 19
- FWCI
- 11.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Highly Active Antiretroviral Therapy and the Incidence of Non–AIDS-Defining Cancers in People With HIV Infection. https://app.cochat.ai/papers/10.1200/jco.2008.19.6626
- The paper
- Powles, T., Robinson, D., Stebbing, J., Shamash, J., Nelson, M., Gazzard, B., Mandelia, S., Møller, H., & Bower, M. (2009). Highly Active Antiretroviral Therapy and the Incidence of Non–AIDS-Defining Cancers in People With HIV Infection. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2008.19.6626
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.